Ultrasound triggered image-guided drug delivery

European Journal of Radiology

Volumn 70, Issue 2, 2009, Pages 242-253

  Böhmer, Marcel R ^a,c   Klibanov, Alexander L ^b   Tiemann, Klaus ^c   Hall, Christopher S ^a   Gruell, Holger ^a   Steinbach, Oliver C ^a  

^a PHILIPS RESEARCH LABORATORIES   (Netherlands)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Image guidance; Microbubbles; MRI; Temperature sensitive liposome; Ultrasound

Indexed keywords

IMAGE GUIDANCE; MICROBUBBLES; MRI; TEMPERATURE SENSITIVE LIPOSOME; ULTRASOUND;

ACOUSTIC WAVES; DRUG DELIVERY; LIPOSOMES; MEDICAL IMAGING; NUCLEIC ACIDS; TECHNOLOGICAL FORECASTING; ULTRASONICS;

ULTRASONIC IMAGING;

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; LIPOSOME; PLASMID DNA; POLYMER; PROTEIN P53; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACOUSTICS; ADVANCED CANCER; ARTICLE; CARDIOLOGY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; HEART MUSCLE PERFUSION; HUMAN; MICROBUBBLE; NONHUMAN; ONCOLOGY; PIEZOELECTRICITY; PRIORITY JOURNAL; SIGNAL DETECTION; TEMPERATURE SENSITIVITY; TRANSDUCER; ULTRASOUND;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; SONICATION; ULTRASONOGRAPHY;

EID: 67349159740     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.01.051     Document Type: Article

References (133)

1. Clement G.T. Perspectives in clinical uses of high-intensity focused ultrasound. Ultrasonics 42 10 (2004) 1087-1093
2. Moyer H.R., and Delman K.A. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 24 3 (2008) 251-261
3. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 60 10 (2008) 1193-1208
4. Ferrara K., Pollard R., and Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9 (2007) 415-447
5. Hernot S., and Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60 10 (2008) 1153-1166
6. Husseini G.A., and Pitt W.G. Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev 60 10 (2008) 1137-1152
7. Hynynen K. Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev 60 10 (2008) 1209-1217
8. Mayer C.R., and Bekeredjian R. Ultrasonic gene and drug delivery to the cardiovascular system. Adv Drug Deliv Rev 60 10 (2008) 1177-1192
9. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 4 3 (2005) 255-260
10. Palussiere J., Salomir R., Le Bail B., et al. Feasibility of MR-guided focused ultrasound with real-time temperature mapping and continuous sonication for ablation of VX2 carcinoma in rabbit thigh. Magn Reson Med 49 1 (2003) 89-98
11. Vimeux F.C., De Zwart J.A., Palussiere J., et al. Real-time control of focused ultrasound heating based on rapid MR thermometry. Invest Radiol 34 3 (1999) 190-193
12. Hokland S.L., Pedersen M., Salomir R., Quesson B., Stodkilde-Jorgensen H., and Moonen C.T.W. MRI-Guided focused ultrasound: Methodology and applications. IEEE Trans Med Imaging 25 6 (2006) 723-731
13. Moonen C.T. Spatio-temporal control of gene expression and cancer treatment using magnetic resonance imaging-guided focused ultrasound. Clin Cancer Res 13 12 (2007) 3482-3489
14. Moonen C.T., Quesson B., Salomir R., et al. Thermal therapies in interventional MR imaging. Focused ultrasound. Neuroimaging Clin N Am 11 4 (2001) 737-747 xi
15. Treat L.H., McDannold N., Vykhodtseva N., Zhang Y., Tam K., and Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121 4 (2007) 901-907
16. Chen S., Shohet R.V., Bekeredjian R., Frenkel P., and Grayburn P.A. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 42 2 (2003) 301-308
17. Li P., Cao L.Q., Dou C.Y., Armstrong W.F., and Miller D. Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med Biol 29 9 (2003) 1341-1349
18. Kondo I., Ohmori K., Oshita A., et al. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J Am Coll Cardiol 44 3 (2004) 644-653
19. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 60 3 (2006) 324-330
20. Schneider M. Molecular imaging and ultrasound-assisted drug delivery. J Endourol 22 4 (2008) 795-801
21. Lencioni R., Della Pina C., Crocetti L., Bozzi E., and Cioni D. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US. Eur Radiol 17 Suppl. 6 (2007) F73-F79
22. Postema M., van Wamel A., Lancee C.T., and de Jong N. Ultrasound-induced encapsulated microbubble phenomena. Ultrasound Med Biol 30 6 (2004) 827-840
23. Emmer M., van Wamel A., Goertz D.E., and de Jong N. The onset of microbubble vibration. Ultrasound Med Biol 33 6 (2007) 941-949
24. van der Meer S.M., Dollet B., Voormolen M.M., et al. Microbubble spectroscopy of ultrasound contrast agents. J Acoust Soc Am 121 1 (2007) 648-656
25. Bloch S.H., Wan M., Dayton P.A., and Ferrara K.W. Optical observation of lipid- and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett 84 4 (2004) 631-633
26. Bouakaz A., Versluis M., and de Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol 31 3 (2005) 391-399
27. Chin C.T., Lancee C., Borsboom J., et al. Brandaris 128: a digital 25 million frames per second camera with 128 highly sensitive frames. Rev Sci Instrum 74 12 (2003) 5026-5034
28. Kooiman K., Bohmer M., Emmer M., et al. Oil-filled polymer microcapsules for ultrasound-mediated delivery of lipophilic drugs. J. Controlled Release 133 (2009) 109-118
29. Marmottant P. unpublished results.
30. Wallez Y., and Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778 3 (2008) 794-809
31. Walsh D.A. Pathophysiological mechanisms of angiogenesis. Adv Clin Chem 44 (2007) 187-221
32. Schmidt B., Souza I., van Beek A., and Bohmer M. Adhesion and ultrasound-induced delivery from monodisperse microbubbles in a parallel plate flow cell. J Control Release 131 (2008) 19-26
33. Korpanty G., Carbon J.G., Grayburn P.A., Fleming J.B., and Brekken R.A. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res 13 1 (2007) 323-330
34. Villanueva F.S., Jankowski R.J., Klibanov S., et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation 98 1 (1998) 1-5
35. Klibanov A.L., Hughes M.S., Marsh J.N., et al. Targeting of ultrasound contrast material, an in vitro feasibility study. Acta Radiol Suppl 412 (1997) 113-120
36. Schumann P.A., Christiansen J.P., Quigley R.M., et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol 37 11 (2002) 587-593
37. Lindner J.R., Song J., Christiansen J., Klibanov A.L., Xu F., and Ley K. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104 17 (2001) 2107-2112
38. Weller G.E., Lu E., Csikari M.M., et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation 108 2 (2003) 218-224
39. Ellegala D.B., Leong-Poi H., Carpenter J.E., et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation 108 3 (2003) 336-341
40. Leong-Poi H., Christiansen J., Heppner P., et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation 111 24 (2005) 3248-3254
41. Willmann J.K., Paulmurugan R., Chen K., et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246 2 (2008) 508-518
42. Schneider M., Pochon S., Tardy I., et al. Angiogenic molecular imaging with KDR-targeted microbubbles. Contrast Media Mol Imaging 2 (2007) 274-304
43. Della Martina A., Allemann E., Bettinger T., et al. Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa-characterization and in vitro testing. Eur J Pharm Biopharm 68 3 (2008) 555-564
44. Takalkar A.M., Klibanov A.L., Rychak J.J., Lindner J.R., and Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 96 3 (2004) 473-482
45. Rychak J.J., Li B., Acton S.T., et al. Selectin ligands promote ultrasound contrast agent adhesion under shear flow. Mol Pharm 3 5 (2006) 516-524
46. Weller G.E., Villanueva F.S., Tom E.M., and Wagner W.R. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng 92 6 (2005) 780-788
47. Klibanov A.L., Rychak J.J., Yang W.C., et al. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow. Contrast Media Mol Imaging 1 6 (2006) 259-266
48. Price R.J., Skyba D.M., Kaul S., and Skalak T.C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 98 13 (1998) 1264-1267
49. Marmottant P., and Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 423 6936 (2003) 153-156
50. Marmottant P., and Hilgenfeldt S. A bubble-driven microfluidic transport element for bioengineering. Proc Natl Acad Sci U S A 101 26 (2004) 9523-9527
51. van Wamel A., Kooiman K., Emmer M., ten Cate F.J., Versluis M., and de Jong N. Ultrasound microbubble induced endothelial cell permeability. J Control Release 116 2 (2006) e100-e102
52. van Wamel A., Kooiman K., Harteveld M., et al. Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release 112 2 (2006) 149-155
53. van Wamel A., Bouakaz A., Bernard B., ten Cate F., and de Jong N. Radionuclide tumour therapy with ultrasound contrast microbubbles. Ultrasonics 42 1-9 (2004) 903-906
54. Mehier-Humbert S., Yan F., Frinking P., Schneider M., Guy R.H., and Bettinger T. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem 18 3 (2007) 652-662
55. Hynynen K., McDannold N., Sheikov N.A., Jolesz F.A., and Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24 1 (2005) 12-20
56. Miller D.L., and Song J.M. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 29 6 (2003) 887-893
57. Miller D.L., and Dou C. The potential for enhancement of mouse melanoma metastasis by diagnostic and high-amplitude ultrasound. Ultrasound Med Biol 32 7 (2006) 1097-1101
58. Shi W.T., Bohmer M., van Wamel A., et al. Ultrasound therapy with drug loaded microcapsules. 2007 IEEE Ultrasonics Symposium (2007) 773-776
59. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., and Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 33 12 (1998) 886-892
60. Hauff P., Seemann S., Reszka R., et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 236 2 (2005) 572-578
61. Lentacker I., De Smedt S.C., Demeester J., and Sanders N.N. Microbubbles which bind and protect DNA against nucleases. J Control Release 116 2 (2006) e73-e75
62. Vandenbroucke R.E., Lentacker I., Demeester J., De Smedt S.C., and Sanders N.N. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles. J Control Release 126 3 (2008) 265-273
63. Borden M.A., Caskey C.F., Little E., Gillies R.J., and Ferrara K.W. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 23 18 (2007) 9401-9408
64. Bohmer M.R., Schroeders R., Steenbakkers J.A.M., et al. Preparation of monodisperse polymer particles and capsules by ink-jet printing. Colloids Surfaces a-Physicochem Eng Aspects 289 1-3 (2006) 96-104
65. Straub J.A., Chickering D.E., Church C.C., Shah B., Hanlon T., and Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release 108 1 (2005) 21-32
66. Palmowski M., Huppert J., Ladewig G., et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther 7 1 (2008) 101-109
67. Palmowski M., Morgenstern B., Hauff P., et al. Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol 43 3 (2008) 162-169
68. Xie F.Y., Woodle M.C., and Lu P.Y. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development. Drug Discov Today 11 1-2 (2006) 67-73
69. Unger E.C., Hersh E., Vannan M., Matsunaga T.O., and McCreery T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 44 1 (2001) 45-54
70. Frenkel P.A., Chen S., Thai T., Shohet R.V., and Grayburn P.A. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 28 6 (2002) 817-822
71. Dayton P.A., Pearson D., Clark J., et al. Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells. Mol Imaging 3 2 (2004) 125-134
72. Vos H.J., Dollet B., Bosch J.G., Versluis M., and de Jong N. Nonspherical vibrations of microbubbles in contact with a wall: a pilot study at low mechanical index. Ultrasound Med Biol 34 4 (2008) 685-688
73. Talu E., Hettiarachchi K., Powell R.L., Lee A.P., Dayton P.A., and Longo M.L. Maintaining monodispersity in a microbubble population formed by flow-focusing. Langmuir 24 5 (2008) 1745-1749
74. Dayton P., Klibanov A., Brandenburger G., and Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med Biol 25 8 (1999) 1195-1201
75. Rychak J.J., Klibanov A.L., Ley K.F., and Hossack J.A. Enhanced targeting of ultrasound contrast agents using acoustic radiation force. Ultrasound Med Biol 33 7 (2007) 1132-1139
76. Wu J., and Nyborg W.L. Ultrasound, cavitation bubbles and their interaction with cells. Adv Drug Deliv Rev 60 10 (2008) 1103-1116
77. Rapoport N., Gao Z., and Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99 14 (2007) 1095-1106
78. Giesecke T., and Hynynen K. Ultrasound-mediated cavitation thresholds of liquid perfluorocarbon droplets in vitro. Ultrasound Med Biol 29 9 (2003) 1359-1365
79. Kong G., and Dewhirst M.W. Hyperthermia and liposomes. Int J Hyperthermia 15 5 (1999) 345-370
80. Frenkel V., Etherington A., Greene M., et al. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 13 4 (2006) 469-479
81. Yuh E.L., Shulman S.G., Mehta S.A., et al. Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology 234 2 (2005) 431-437
82. Horsman M.R. Angiogenesis and vascular targeting: relevance for hyperthermia. Int J Hyperthermia 24 1 (2008) 57-65
83. Dromi S., Frenkel V., Luk A., et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 13 9 (2007) 2722-2727
84. Friedman M., Mikityansky I., Kam A., et al. Radiofrequency ablation of cancer. Cardiovasc Int Radiol 27 5 (2004) 427-434
85. Pankhurst Q.A., Connolly J., Jones S.K., and Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D-Appl Phys 36 13 (2003) R167-R181
86. Salomir R., Palussiere J., Fossheim S.L., et al. Local delivery of magnetic resonance (MR) contrast agent in kidney using thermosensitive liposomes and MR imaging-guided local hyperthermia: a feasibility study in vivo. J Magn Reson Imaging 22 4 (2005) 534-540
87. Bos C., Lepetit-Coiffe M., Quesson B., and Moonen C.T.W. Simultaneous monitoring of temperature and T-1: methods and preliminary results of application to drug delivery using thermosensitive liposomes. Magn Reson Med 54 4 (2005) 1020-1024
88. Deckers R., Rome C., and Moonen C.T. The role of ultrasound and magnetic resonance in local drug delivery. J Magn Reson Imaging 27 2 (2008) 400-409
89. Rijcken C.J., Soga O., Hennink W.E., and van Nostrum C.F. Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release 120 3 (2007) 131-148
90. Chilkoti A., Dreher M.R., Meyer D.E., and Raucher D. Targeted drug delivery by thermally responsive polymers. Adv Drug Deliv Rev 54 5 (2002) 613-630
91. Meyer D.E., Shin B.C., Kong G.A., Dewhirst M.W., and Chilkoti A. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 74 1-3 (2001) 213-224
92. Ganta S., Devalapally H., Shahiwala A., and Amiji M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release 126 3 (2008) 187-204
93. Oh K.T., Yin H.Q., Lee E.S., and Bae Y.H. Polymeric nanovehicles for anticancer drugs with triggering release mechanisms. J Mater Chem 17 (2007) 3987-4001
94. Liu X.M., and Wang L.S. A one-pot synthesis of oleic acid end-capped temperature- and pH-sensitive amphiphilic polymers. Biomaterials 25 10 (2004) 1929-1936
95. Liu X.M., Pramoda K.P., Yang Y.Y., Chow S.Y., and He C.B. Cholesteryl-grafted functional amphiphilic poly(N-isopropylacrylamide-co-N-hydroxylmethylacrylamide): synthesis, temperaturesensitivity, self-assembly and encapsulation of a hydrophobic agent. Biomaterials 25 13 (2004) 2619-2628
96. Liu S.Q., Wiradharma N., Gao S.J., Tong Y.W., and Yang Y.Y. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 28 7 (2007) 1423-1433
97. Liu B.R., Yang M., Li R.T., et al. The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm 69 2 (2008) 527-534
98. Na K., Lee K.H., Lee D.H., and Bae Y.H. Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier. Eur J Pharm Sci 27 2-3 (2006) 115-122
99. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharm Rev 51 4 (1999) 691-743
100. Yatvin M.B., Muhlensiepen H., Porschen W., Weinstein J.N., and Feinendegen L.E. Selective delievery of liposome-associated cis-diclorodiammineplatium (II) by heat and its influence on tumor uptake and growth. Cancer Res 41 5 (1981) 1602-1607
101. Ponce A.M., Vujaskovic Z., Yuan F., Needham D., and Dewhirst M.W. Hyperthermia mediated liposomal drug delivery. Int J Hyperthermia 22 3 (2006) 205-213
102. Viglianti B.L., Ponce A.M., Michelich C.R., et al. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med 56 5 (2006) 1011-1018
103. Needham D., and Dewhirst M.W. The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors. Adv Drug Deliv Rev 53 3 (2001) 285-305
104. Mills J.K., and Needham D. The materials engineering of temperature-sensitive liposomes. Methods Enzymol 387 (2004) 82-113
105. Anyarambhatla G.R., and Needham D. Enhancement of the phase transition permeability of DPPC liposomes by incorporation of MPPC: a new temperature-sensitive liposome for use with mild hyperthermia. J Liposome Res 9 4 (1999) 491-506
106. Celsion. www.celsioncom.
107. Kleiter M.M., Yu D.H., Mohammadian L.A., et al. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral Doxil extravasation. Clin Cancer Res 12 22 (2006) 6800-6807
108. Ponce A.M., Viglianti B.L., Yu D., et al. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst 99 1 (2007) 53-63
109. Viglianti B.L., Abraham S.A., MacFall J.R., Bally M.B., and Dewhirst M.W. In vivo monitoring of real time tissue pharmacokinetics of liposome/drug concentration using MRI. Radiology 225 (2002) 647-648
110. Viglianti B.L., Abraham S.A., Michelich C.R., et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery. Magn Reson Med 51 6 (2004) 1153-1162
111. Kono K., Yoshino K., and Takagishi T. Effect of poly(ethylene glycol) grafts on temperature-sensitivity of thermosensitive polymer-modified liposomes. J Control Release 80 1-3 (2002) 321-332
112. Kono K. Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev 53 3 (2001) 307-319
113. Chen Q., Tong S., Dewhirst M.W., and Yuan F. Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. Mol Cancer Ther 3 10 (2004) 1311-1317
114. Amyot R., Morales M.A., and Rovai D. Contrast echocardiography for myocardial perfusion imaging using intravenous agents: progress and promises. Eur J Echocardiogr 1 4 (2000) 233-243
115. Mayer S., and Grayburn P.A. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis 44 1 (2001) 33-44
116. Shohet R.V., Chen S., Zhou Y.T., et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 101 22 (2000) 2554-2556
117. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., and Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108 8 (2003) 1022-1026
118. Bekeredjian R., Grayburn P.A., and Shohet R.V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 45 3 (2005) 329-335
119. Korpanty G., Chen S., Shohet R.V., et al. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther 12 17 (2005) 1305-1312
120. Korpanty G., Grayburn P.A., Shohet R.V., and Brekken R.A. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol 31 9 (2005) 1279-1283
121. Thuroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17 8 (2003) 673-677
122. Haussecker D. The business of RNAi therapeutics. Hum Gene Ther 19 5 (2008) 451-462
123. Reischl D., and Zimmer A. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomedicine (2008)
124. Minchinton A.I., and Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 6 8 (2006) 583-592
125. Lake R.A., and Robinson B.W. Immunotherapy and chemotherapy-a practical partnership. Nat Rev Cancer 5 5 (2005) 397-405
126. Witz I.P. Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res 100 (2008) 203-229
127. Galmarini C.M., and Galmarini F.C. Multidrug resistance in cancer therapy: role of the microenvironment. Curr Opin Investig Drugs 4 12 (2003) 1416-1421
128. McDonald D.M., and Choyke P.L. Imaging of angiogenesis: from microscope to clinic. Nat Med 9 6 (2003) 713-725
129. Jain R.K. Antiangiogenic therapy for cancer: current and emerging concepts. Oncology (Williston Park) 19 4 Suppl 3 (2005) 7-16
130. Boucher Y., Baxter L.T., and Jain R.K. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50 15 (1990) 4478-4484
131. Di Paolo A., and Bocci G. Drug distribution in tumors: mechanisms, role in drug resistance, and methods for modification. Curr Oncol Rep 9 2 (2007) 109-114
132. Greenberger S., Shaish A., Varda-Bloom N., et al. Transcription-controlled gene therapy against tumor angiogenesis. J Clin Invest 113 7 (2004) 1017-1024
133. Russ V., and Wagner E. Cell and tissue targeting of nucleic acids for cancer gene therapy. Pharm Res 24 6 (2007) 1047-1057